Related references
Note: Only part of the references are listed.Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant antioxidant imbalance in periphery and brain of BTBR T plus tf/J mice
Ahmed Nadeem et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Isothiocyanate from Broccoli, Sulforaphane, and Its Properties
Alena Vanduchova et al.
JOURNAL OF MEDICINAL FOOD (2019)
The neuroprotective mechanisms and effects of sulforaphane
Eric A. Klomparens et al.
BRAIN CIRCULATION (2019)
New highlights on the health-improving effects of sulforaphane
Alfredo Briones-Herrera et al.
FOOD & FUNCTION (2018)
Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli
Stephen Bent et al.
MOLECULAR AUTISM (2018)
Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options
Jung Won Kim et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2018)
Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice
Pablo Ferreira-Chamorro et al.
FRONTIERS IN PHARMACOLOGY (2018)
Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism
Sheikh Fayaz Ahmad et al.
MOLECULAR NEUROBIOLOGY (2017)
Autism Spectrum Disorders - Diagnosis and Management
Sharmila Banerjee Mukherjee
INDIAN JOURNAL OF PEDIATRICS (2017)
The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism
William Parker et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation
Ji-Chun Zhang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder
Anne Masi et al.
NEUROSCIENCE BULLETIN (2017)
Mitochondria! dysfunction in Autism Spectrum Disorder: clinical features and perspectives
Fiona Hollis et al.
CURRENT OPINION IN NEUROBIOLOGY (2017)
Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders
Kunio Yui et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2016)
Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia
Vicente Hernandez-Rabaza et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Irritability and Problem Behavior in Autism Spectrum Disorder: A Practice Pathway for Pediatric Primary Care
Kelly McGuire et al.
PEDIATRICS (2016)
Inflammatory Cytokines: Potential Biomarkers of Immunologic Dysfunction in Autism Spectrum Disorders
Ningan Xu et al.
MEDIATORS OF INFLAMMATION (2015)
Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism
Irena Smaga et al.
PHARMACOLOGICAL REPORTS (2015)
A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism
Ali Ghaleiha et al.
PSYCHIATRY RESEARCH (2015)
The epidemiology and global burden of autism spectrum disorders
A. J. Baxter et al.
PSYCHOLOGICAL MEDICINE (2015)
The Antioxidant Properties of Organosulfur Compounds (Sulforaphane)
Sonia M. de Figueiredo et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2015)
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
Nazila Shahmansouri et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial
Ali Ghaleiha et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Sulforaphane treatment of autism spectrum disorder (ASD)
Kanwaljit Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Autism spectrum disorders: a pediatric overview and update
Alexis Tchaconas et al.
CURRENT OPINION IN PEDIATRICS (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
Mahtab Asadabadi et al.
PSYCHOPHARMACOLOGY (2013)
Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
Ali Ghaleiha et al.
PEDIATRIC DRUGS (2013)
Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells
Megan L. Steele et al.
REDOX BIOLOGY (2013)
Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
Danial Khajavi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Drug therapy in autism: a present and future perspective
Baldeep Kumar et al.
PHARMACOLOGICAL REPORTS (2012)
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
Paul Ashwood et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Defining the cognitive phenotype of autism
T. Charman et al.
BRAIN RESEARCH (2011)
Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
James B. Adams et al.
NUTRITION & METABOLISM (2011)
Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
Shahin Akhondzadeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Elevated immune response in the brain of autistic patients
Xiaohong Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Brief Report: The Vineland Adaptive Behavior Scales in Young Children with Autism Spectrum Disorders at Different Cognitive Levels
Adrienne Perry et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2009)
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial
Shahrokh Amiri et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Elevated cytokine levels in children with autism spectrum disorder
CA Molloy et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
G Chouinard et al.
SCHIZOPHRENIA RESEARCH (2005)
Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism
SJ James et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2004)
Share Paper
